The new biological medicine Ilaris® (canakinumab) has been approved in the EU to treat adults and children as young as four years old with CAPS, a rare life-long auto-inflammatory disease.
30 October, 2009
The U.S. Food and Drug Administration has approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukaemia, a slowly progressing cancer of the blood and bone marrow.
29 October, 2009
Could exposure to the H1N1 pandemic flu virus protect people from H5N1 bird flu?
28 October, 2009
Rexahn Pharmaceuticals, Inc. recently announced the results of an animal study that demonstrates Archexin’s potential to target and treat multiple life-threatening cancers.
28 October, 2009
Human Genome Sciences, Inc. and GlaxoSmithKline PLC recently announced the full presentation of results from BLISS-52, the first of two Phase III trials of BENLYSTA™ (belimumab) in seropositive patients with systemic lupus erythematosus.
27 October, 2009
New results have shown that the novel biological therapy ACZ885 (canakinumab) is significantly more effective than an injectable corticosteroid at reducing pain and preventing recurrent attacks or ‘flares’ in patients with hard-to-treat gout, one of the most painful forms of arthritis.
26 October, 2009
A new spin out company from the Medical Research Council’s Laboratory of Molecular Biology in Cambridge UK was announced this week. Bicycle Therapeutics is a new biotechnology company developing a novel technology platform for the creation of a new class of therapeutic entity which combines the most desirable features of small molecules and biologics.
23 October, 2009
Scientists have for the first time produced liver cells from adult skin cells using the induced pluripotent stem cell technology.
23 October, 2009
ELRIG (The European Laboratory Robotic Interest Group) has a mission to give back to the Industry whenever they can and to encourage the growth of Innovative Technology. It was therefore very appropriate that they agreed to Sponsor the Technobotts in their venture to enter the RoboCup 2010 in Singapore.
22 October, 2009
The European Federation of Pharmaceutical Industries and Associations, the ‘voice of the research-based pharmaceutical industry in Europe’, today unveiled its pilot project to verify medicines and help reduce the risk of counterfeit medicines being dispensed to patients.
21 October, 2009
Scientists are developing new scaffolding technology that could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures.
20 October, 2009
Scientists in the United Kingdom are reporting an advance toward overcoming one of the key challenges in nanotechnology: getting molecules to move quickly in a desired direction without help from outside forces.
19 October, 2009
GlaxoSmithKline (GSK) has recently announced the final results from its four-year combination therapy with Avodart and tamsulosin (CombAT) study.
16 October, 2009
Dr Leroy Hood-led venture has secured $30 million Series A financing from InterWest Partners, Wellcome Trust and dievini.
15 October, 2009
Scientists have discovered why a group of cancer drugs are so effective in treating the disease. Although they have been used for many years to treat certain tumours, researchers didn't know how they worked until now.
14 October, 2009
Data presented at the American Society of Retina Specialists Conference in New York.
12 October, 2009
Cancer Research UK scientists at the University of Southampton have developed a potential new antibody treatment that, in the laboratory, shows significantly increased survival from neuroblastoma, a form of childhood cancer that grows from undeveloped tissue of the nervous system.
09 October, 2009
Olesoxime in ongoing pivotal efficacy study for amyotrophic lateral sclerosis.
08 October, 2009
BioFocus has recently launched its new microsite, www.SilenceSelect.com, which is dedicated to the SilenceSelect® and FLeXSelect® adenoviral technology.
08 October, 2009
Prisoners get drunk on alcohol hand gel. Many Muslims can’t even use it. According to a Manchester-based company, alcohol hand gel should be ‘a thing of the past’.
07 October, 2009
The antibiotic minocycline could revolutionize the treatment of strokes.
06 October, 2009
Major new collaboration announced at Clinton Global Initiative Annual Meeting.
06 October, 2009
Sanofi-aventis announced recently that it has signed a binding agreement for the acquisition of Fovea Pharmaceuticals SA (‘Fovea‘), a privately held French research and development biopharmaceutical company, focused on ocular diseases.
05 October, 2009
A provocative new theory – that breast cancer cells can self-seed by wandering off around the body and returning to the primary tumour or can stay in the body for several decades after the disease seems to be cured before growing or seeding in other organs – could pave the way for new therapies to destroy the wandering cells that have escaped initial treatment.
05 October, 2009
Multi-disciplinary healthcare giant Abbott Laboratories has fought off competition from Nycomed to secure the $6.6 billion acquisition of Solvay's pharmaceutical business.
02 October, 2009